IP Library Granted Patent US 7,101,672
Granted Patent B2
US 7,101,672 · App. 10/655,362 · Granted Sep 5, 2006

Target-dependent reactions using structure-bridging oligonucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,101,672
App. No.
10/655,362
Granted
Sep 5, 2006
Kind
B2
Abstract

The present invention relates to methods and compositions for analyzing nucleic acids. In particular, the present invention provides methods and compositions for the detection and characterization of nucleic acids and sequence changes. The methods of the present invention permit the detection and/or identification of genetic polymorphism such as those associated with human disease and permit the identification of pathogens (e.g., viral and bacterial strain identification).

Claims (46)

1. A method, comprising:

a) providing:

i) target nucleic acid comprising first and second non-contiguous single-stranded regions separated by a secondary structure;

ii) a first oligonucleotide that hybridizes across said secondary structure;

iii) a second oligonucleotide capable of binding to a portion of said first non-contiguous single-stranded region; and

iv) a 5′ nuclease;

b) mixing said target nucleic acid, said first oligonucleotide, said second oligonucleotide, and said 5′ nuclease under conditions such that a cleavage structure is formed and either said first oligonucleotide or said second oligonucleotide is cleaved.

2. The method of claim 1 , wherein said secondary structure comprises a hairpin loop region.

3. The method of claim 1 , wherein said secondary structure comprises a bend region.

4. The method of claim 1 , wherein said secondary structure comprises a bulge region.

5. The method of claim 1 , wherein said secondary structure comprises a stem-loop region.

6. The method of claim 1 , wherein said 5′ nuclease is thermostable.

7. The method of claim 1 , wherein said target nucleic acid is DNA.

8. The method of claim 7 , wherein said DNA is viral DNA.

9. The method of claim 1 , wherein said target nucleic acid is RNA.

10. The method of claim 9 , wherein said RNA is viral RNA.

11. The method of claim 1 , further comprising:

c) detecting the cleavage of said cleavage structure.

12. The method of claim 11 , wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence energy transfer.

13. The method of claim 11 , wherein said detecting the cleavage of said cleavage structure comprises detection selected from the group consisting of detection of radioactivity, luminescence, phosphorescence, fluorescence polarization, and charge.

14. The method of claim 1 , wherein said first oligonucleotide is attached to a solid support.

15. The method of claim 1 , wherein said second oligonucleotide is attached to a solid support.

16. A method, comprising:

a) providing:

i) target nucleic acid comprising first and second non-contiguous single-stranded regions separated by a secondary structure;

ii) a first oligonucleotide that hybridizes across said secondary structure, wherein said first oligonucleotide comprises a region complementary to said first non-contiguous single-stranded region of said target nucleic acid;

iii) a second oligonucleotide capable of binding to a portion of said second non-contiguous single-stranded region, wherein said second oligonucleotide comprises a 3′ portion and a 5′ portion, wherein said 5′ portion comprises a region complementary to said second non-contiguous single-stranded region of said target nucleic acid; and

iv) a 5′ nuclease;

b) mixing said target nucleic acid, said first oligonucleotide, said second oligonucleotide, and said 5′ nuclease under conditions such that said first oligonucleotide hybridizes with said first non-contiguous single-stranded region of said target nucleic acid and such that said 5′ portion of said second oligonucleotide hybridizes with said second non-contiguous single-stranded region of said target nucleic acid so as to form a cleavage structure, wherein said 5′ nuclease cleaves said cleavage structure.

17. The method of claim 16 , wherein said cleaving of said cleavage structure comprises cleavage of said first oligonucleotide.

18. The method of claim 16 , wherein said cleaving of said cleavage structure comprises cleavage of said second oligonucleotide.

19. The method of claim 16 , wherein said secondary structure comprises a hairpin loop region.

20. The method of claim 16 , wherein said secondary structure comprises a bend region.

21. The method of claim 16 , wherein said secondary structure comprises a bulge region.

22. The method of claim 16 , wherein said secondary structure comprises a stem-loop region.

23. The method of claim 16 , wherein said 5′ nuclease is thermostable.

24. The method of claim 16 , wherein said target nucleic acid is DNA.

25. The method of claim 24 , wherein said DNA is viral DNA.

26. The method of claim 16 , wherein said target nucleic acid is RNA.

27. The method of claim 26 , wherein said RNA is viral RNA.

28. The method of claim 16 , further comprising:

c) detecting the cleavage of said cleavage structure.

29. The method of claim 28 , wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence energy transfer.

30. The method of claim 28 , wherein said detecting the cleavage of said cleavage structure comprises detection selected from the group consisting of detection of radioactivity, luminescence, phosphorescence, fluorescence polarization, and charge.

31. The method of claim 16 , wherein said first oligonucleotide is attached to a solid support.

32. The method of claim 16 , wherein said second oligonucleotide is attached to a solid support.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
MERGER Recorded Oct 23, 2015
From: THIRD WAVE AGBIO, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: GEN-PROBE INCORPORATED
Reel/Frame 036934/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 25, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024944/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2008
From: DONG, FANG; LYAMICHEV, VICTOR I.; PRUDENT, JAMES R.; FORS, LANCE; NERI, BRUCE P.; BROW, MARY ANN D.; ANDERSON, TODD A.; DAHLBERG, JAMES E.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 021617/0653 →
SECURITY AGREEMENT Recorded Jul 29, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0780 →